Pfizer Files Proxy Supplement for 2024 Annual Meeting

TL;DR

Pfizer dropped more proxy docs for the 2024 meeting. No fee.

AI Summary

Pfizer Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on March 28, 2024, supplementing its Notice of 2024 Annual Meeting. This filing is related to the company's proxy materials and does not involve a fee, as indicated by the 'No fee required' checkbox. The filing is made under the 1934 Securities Exchange Act.

Why It Matters

This filing provides additional information to shareholders regarding the upcoming 2024 Annual Meeting, ensuring they have the necessary details for voting on company matters.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to proxy materials for an annual meeting, not indicating any immediate financial or operational risks.

Key Players & Entities

• Pfizer Inc. (company) — Registrant
• 0000078003-24-000086 (filing_id) — Accession Number
• 20240328 (date) — Filing Date

FAQ

From the Filing

0000078003-24-000086.txt : 20240328 0000078003-24-000086.hdr.sgml : 20240328 20240328161007 ACCESSION NUMBER: 0000078003-24-000086 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24798961 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 DEFA14A 1 pfe_-xproxyxsupplement1224.htm DEFA14A PFIZER SUPPLEMENT PROXY Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party Other Than the Registrant ¨ Check the Appropriate Box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to §240.14a-12 Pfizer Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of filing fee (Check all boxes that apply): x No fee required ¨ Fee paid previously with preliminary materials ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 66 Hudson Boulevard East New York, New York 10001 SUPPLEMENT TO NOTICE OF 2024 ANNUAL MEETING AND PROXY STATEMENT FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 25, 2024 March 28, 2024 This Supplement provides updated information with respect to the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Pfizer Inc. (“Pfizer”) to be held on April 25, 2024. On March 14, 2024, Pfizer commenced distribution of the Notice of Annual Meeting and Proxy Statement (the “Proxy Statement”) for the Annual Meeting and notice of availability of the Proxy Statement. This Supplement should be read in conjunction with the Proxy Statement. Withdrawal of Shareholder Proposal The proponent of Item 7 – Amend Director Resignation Processes (“Item 7”) has withdrawn the proposal. Therefore, Item 7 will not be presented or voted upon at the Annual Meeting, nor will any votes cast in regard to Item 7 be tabulated or reported. Voting Matters Notwithstanding the withdrawal of Item 7, the proxy card and voting instruction forms distributed or presented online with the Proxy Statement remain valid, and Pfizer will not distribute new voting instructions or proxy cards. None of the other agenda items presented in the Proxy Statement are affected by this Supplement, and shares represented by proxy cards or voting instruction forms returned before the Annual Meeting will be voted with respect to all other matters properly brought before the Annual Meeting as instructed on the proxy card or voting instruction form. If you have already returned your proxy card or voting instruction form, you do not need to take any action unless you wish to change your vote. If you have not yet returned your proxy card or voting instruction form, please complete the proxy card or voting instruction form, disregarding Item 7. Information on how to vote your shares, or change or revoke your prior vote or voting instruction, is available in the Proxy Statement. GRAPHIC 2 pfizerlogoaa.jpg begin 644 pfizerlogoaa.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1"B1